InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+57.2%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by MANNINO RAPHAEL J, Directeur Scientifique. Officer active across 1 company, notably Matinas BioPharma Holdings, Inc.. Cumulatively, 4 disclosures have been recorded. History available since 19 June 2021. The latest transaction was disclosed on 3 September 2021 (J). Regulator: SEC (Form 4). The full history is openly available.
Declarations4 total
462,150 shares0Common Stock, par value $0.0001 per shareSEC:0001493152-21-022716:0
462,150 shares0Common Stock, par value $0.0001 per shareSEC:0001493152-21-022716
8,000 shares0Common Stock, par value $0.0001 per shareSEC:0000905718-21-000822
8,000 shares0Common Stock, par value $0.0001 per shareSEC:0000905718-21-000822:0
4 of 4 declarations
About MANNINO RAPHAEL J
Raphael J. Mannino is the Chief Scientific Officer at Matinas BioPharma Holdings, Inc. He oversees the company's research and development initiatives, contributing to innovation in the pharmaceutical sector. His scientific expertise is crucial for the company's success.
